Search
Sodium/potassium-transporting ATPase subunit alpha-2
go.drugbank.com/bio_entities/BE0005034TargetTransporterHumansCatalytic subunit of the Na(+)/K(+)-ATPase that hydrolyzes ATP to exchange ions across the plasma membrane, exporting 3 Na(+) and importing 2 K(+) per cycle (PubMed:33880529).
Polypeptides: Sodium/potassium-transporting ATPase subunit alpha-2Synonyms: Sodium pump subunit alpha-2, Na(+)/K(+) ATPase alpha-2 subunitNucleotide-binding oligomerization domain-containing protein 2
go.drugbank.com/bio_entities/BE0009323TargetHumansPattern recognition receptor (PRR) that detects bacterial peptidoglycan fragments and other danger signals and plays an important role in gastrointestinal immunity (PubMed:12514169, PubMed:12527755, PubMed:12626759, PubMed:15044951, PubM...
Polypeptides: Nucleotide-binding oligomerization domain-containing protein 2Sodium-coupled neutral amino acid symporter 2
go.drugbank.com/bio_entities/BE0009871TransporterHumansSymporter that cotransports neutral amino acids and sodium ions from the extracellular to the intracellular side of the cell membrane (PubMed:10930503, PubMed:15774260, PubMed:15922329, PubMed:16621798). The transport is pH-sensitive, Li...
Polypeptides: Sodium-coupled neutral amino acid symporter 2Synonyms: Solute carrier family 38 member 2, System A amino acid transporter 2Very long chain fatty acid elongase 2
go.drugbank.com/bio_entities/BE0009936TargetHumansThis endoplasmic reticulum-bound enzymatic process allows the addition of 2 carbons to the chain of long- and very long-chain fatty acids (VLCFAs) per cycle.
Polypeptides: Very long chain fatty acid elongase 2Synonyms: ELOVL FA elongase 2, ELOVL fatty acid elongase 2Triggering receptor expressed on myeloid cells 2
go.drugbank.com/bio_entities/BE0020451TargetHumansForms a receptor signaling complex with TYROBP which mediates signaling and cell activation following ligand binding (PubMed:10799849). Acts as a receptor for amyloid-beta protein 42, a cleavage product of the amyloid-beta precursor prot...
Polypeptides: Triggering receptor expressed on myeloid cells 2Synonyms: TREM-2, Triggering receptor expressed on monocytes 2Cetrorelix
go.drugbank.com/drugs/DB00050ApprovedInvestigationalCetrorelix is a man-made hormone that blocks the effects of Gonadotropin Releasing Hormone (GnRH).
Products: CETROTIDE 3 MG., CETROTIDE 3 MG ENJEKSİYON İÇİN LİYOFİLİZE TOZ İÇEREN FLAKON, 1 ADETColloidal oatmeal
go.drugbank.com/drugs/DB11286ApprovedNutraceuticalIt is available in topical products as a skin soothing agent. … Colloidal oatmeal is a FDA-approved skin protectant that temporarily protects and helps relieve minor skin irritation and itching due to rashes, eczema, poison ivy, oak, sumac, or insect bites.
Mixtures: Pediadermics Eczema 3, 5% Oat Facial CleanserProducts: Eczema Relief Soothing 2% Colloidal Oatmeal, Eczema Relief Soothing Wash 2% Colloidal OatmealVoriconazole
go.drugbank.com/drugs/DB00582ApprovedInvestigational[A236050] Voriconazole was approved by the FDA under the trade name Vfend on May 24, 2002.[L34660] … Voriconazole (Vfend, Pfizer) is a triazole antifungal medication used to treat serious fungal infections.
Synonyms: (R-(R*,S*))-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol, (αR,βS)-α-(2,4-difluorophenyl)-5-fluoro-β-methyl-α(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanolCategories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP2B6 InhibitorsEdoxaban
go.drugbank.com/drugs/DB09075ApprovedInvestigationalEdoxaban is a member of the Novel Oral Anti-Coagulants (NOACs) class of drugs, and is a rapidly acting, oral, selective factor Xa inhibitor. … 10 days of initial therapy with a parenteral anticoagulant.
Categories: P-glycoprotein substrates, Heterocyclic Compounds, 1-RingProducts: LIXIANA 30 MG FILM KAPLI TABLET ,TABLET, 28 ADET, LIXIANA 60 MG FILM KAPLI TABLET ,TABLET, 28 ADETAgalsidase beta
go.drugbank.com/drugs/DB00103ApprovedInvestigationalAgalsidase beta is a recombinant human α-galactosidase A similar to [agalsidase alfa]. … [A220343] Agalsidase beta was granted FDA approval on 24 April 2003.[L16383]
Products: REPLAGAL 1 MG/ML IV İNFÜZYONLUK KONSANTRE ÇÖZELTİ, 1 ADET, FABRAZYME 35 MG İNFÜZYONLUK ÇÖZELTİ İÇİN KONSANTRE TOZ, 1 ADET